Related Experiment Video
Updated: Mar 7, 2026

13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
10.0K
Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.
Ian D Danford1, Lana D Verkuil1, Daniel J Choi1
1Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Progress in Retinal and Eye Research
|February 23, 2017
Summary
Primary open-angle glaucoma (POAG) involves complex genetics. This study identified 542 POAG-associated genes, revealing inflammation and senescence as key factors, with TGF-β signaling central to the disease model.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Primary open-angle glaucoma (POAG) is a complex neurodegenerative disease with a multifactorial etiology.
- The genetic landscape of POAG is continually expanding, necessitating comprehensive analysis of known associated genes.
Purpose of the Study:
- To systematically compile and analyze genes associated with POAG and related ocular conditions.
- To elucidate the molecular pathways and biological processes underlying POAG pathogenesis.
- To propose a novel molecular model for POAG incorporating key identified pathways.
Main Methods:
- Bioinformatics tools were employed for a systematic literature search to identify POAG-associated genes.
- Compiled 542 genes linked to POAG and its phenotypes (normal tension glaucoma, ocular hypertension, juvenile open-angle glaucoma, primary congenital glaucoma).
- Functional annotation and pathway analyses were performed on the compiled gene set, classifying genes by ocular tissue and phenotype.
Main Results:
- No single molecular pathway fully explains POAG pathophysiology.
- Inflammation and senescence emerged as critical factors in retinal ganglion cell degeneration.
- The TGF-β signaling pathway was consistently implicated across analyses, suggesting a central role in POAG manifestation.
Conclusions:
- POAG pathogenesis is complex, involving multiple interacting pathways.
- A molecular model centered on TGF-β signaling, integrating inflammation and senescence, is proposed for POAG.
- Emerging molecular therapies targeting these pathways show promise for future POAG treatment.
Related Concept Videos
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K

